Patents Assigned to Evolve Biotherapeutics Co., Ltd.
  • VACCINIA VIRUS THAT INDUCES CELL FUSION AND USE THEREOF
    Publication number: 20220313761
    Abstract: This invention provides a vaccinia virus that induces cell fusion between infected cells and a method for producing the same. Such vaccinia virus is deprived of the K2L gene or the HA gene or functions of the K2L gene and the HA gene and is mutated to induce cell fusion between infected cells and induce cell death.
    Type: Application
    Filed: May 12, 2020
    Publication date: October 6, 2022
    Applicants: National University Corporation Tottori University, Evolve Biotherapeutics Co., Ltd.
    Inventors: Takafumi Nakamura, Nozomi Kuwano, Motomu Nakatake, Hajime Kurosaki